|
1
|
Kumar A, Ellis P, Arabi Y, Roberts D,
Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, et al:
Initiation of inappropriate antimicrobial therapy results in a
fivefold reduction of survival in human septic shock. Chest.
136:1237–1248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schuetz P, Maurer P, Punjabi V, Desai A,
Amin DN and Gluck E: Procalcitonin decrease over 72 hours in US
critical care units predicts fatal outcome in sepsis patients. Crit
Care. 17:R1152013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Standage SW and Wong HR: Biomarkers for
pediatric sepsis and septic shock. Expert Rev Anti Infect Ther.
9:71–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dellinger RP, Levy MM, Carlet JM, Bion J,
Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale
R, et al: Surviving sepsis campaign: International guidelines for
management of severe sepsis and septic shock: 2008. Crit Care Med.
36:296–327. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alqahtani MF, Smith CM, Weiss SL, Dawson
S, Ranaivo Ralay H and Wainwright MS: Evaluation of new diagnostic
biomarkers in pediatric sepsis: Matrix Metalloproteinase-9, tissue
inhibitor of metalloproteinase-1, mid-regional pro-atrial
natriuretic peptide, and adipocyte fatty-acid binding protein. PLoS
One. 11:e01536452016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gucyetmez B and Atalan HK: C-reactive
protein and hemogram parameters for the non-sepsis systemic
inflammatory response syndrome and sepsis: What do they mean? PLoS
One. 11:e01486992016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gearing DP, Comeau MR, Friend DJ, Gimpel
SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B,
et al: The IL-6 signal transducer, gp130: An oncostatin M receptor
and affinity converter for the LIF receptor. Science.
255:1434–1437. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hänel KH, Pfaff CM, Cornelissen C, Amann
PM, Marquardt Y, Czaja K, Kim A, Lüscher B and Baron JM: Control of
the physical and antimicrobial skin barrier by an IL-31-IL-1
signaling network. J Immunol. 196:3233–3244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kasutani K, Fujii E, Ohyama S, Adachi H,
Hasegawa M, Kitamura H and Yamashita N: Anti-IL-31 receptor
antibody is shown to be a potential therapeutic option for treating
itch and dermatitis in mice. Br J Pharmacol. 171:5049–5058.
2014.PubMed/NCBI
|
|
10
|
Hwang JS, Kim GC, Park E, Kim JE, Chae CS,
Hwang W, Lee C, Hwang SM, Wang HS, Jun CD, et al: NFAT1 and JunB
cooperatively regulate IL-31 gene expression in CD4+ T cells in
health and disease. J Immunol. 194:1963–1974. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kasraie S, Niebuhr M and Werfel T:
Interleukin (IL)-31 activates signal transducer and activator of
transcription (STAT)-1, STAT-5 and extracellular signal-regulated
kinase 1/2 and down-regulates IL-12p40 production in activated
human macrophages. Allergy. 68:739–747. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kunsleben N, Rüdrich U, Gehring M, Novak
N, Kapp A and Raap U: IL-31 induces chemotaxis, calcium
mobilization, release of reactive oxygen species, and CCL26 in
eosinophils, which are capable to release IL-31. J Invest Dermatol.
135:1908–1911. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Perrigoue JG, Li J, Zaph C, Goldschmidt M,
Scott P, de Sauvage FJ, Pearce EJ, Ghilardi N and Artis D:
IL-31-IL-31R interactions negatively regulate type 2 inflammation
in the lung. J Exp Med. 204:481–487. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perrigoue JG, Zaph C, Guild K, Du Y and
Artis D: IL-31-IL-31R interactions limit the magnitude of Th2
cytokine-dependent immunity and inflammation following intestinal
helminth infection. J Immunol. 182:6088–6094. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schmidt RL and Lenz LL: Distinct licensing
of IL-18 and IL-1β secretion in response to NLRP3 inflammasome
activation. PLoS One. 7:e451862012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brydges SD, Broderick L, McGeough MD, Pena
CA, Mueller JL and Hoffman HM: Divergence of IL-1, IL-18, and cell
death in NLRP3 inflammasomopathies. J Clin Invest. 123:4695–4705.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
van de Veerdonk FL, Netea MG, Dinarello CA
and Joosten LA: Inflammasome activation and IL-1β and IL-18
processing during infection. Trends Immunol. 32:110–116. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ketelut-Carneiro N, Silva GK, Rocha FA,
Milanezi CM, Cavalcanti-Neto FF, Zamboni DS and Silva JS: IL-18
triggered by the Nlrp3 inflammasome induces host innate resistance
in a pulmonary model of fungal infection. J Immunol. 194:4507–4517.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rittirsch D, Huber-Lang MS, Flierl MA and
Ward PA: Immunodesign of experimental sepsis by cecal ligation and
puncture. Nat Protoc. 4:31–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ding AH, Nathan CF and Stuehr DJ: Release
of reactive nitrogen intermediates and reactive oxygen
intermediates from mouse peritoneal macrophages. Comparison of
activating cytokines and evidence for independent production. J
Immunol. 141:2407–2412. 1988.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Caserta S, Kern F, Cohen J, Drage S,
Newbury SF and Llewelyn MJ: Circulating plasma microRNAs can
differentiate human sepsis and systemic inflammatory response
syndrome (SIRS). Sci Rep. 6:280062016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Müller B, Becker KL, Schächinger H,
Rickenbacher PR, Huber PR, Zimmerli W and Ritz R: Calcitonin
precursors are reliable markers of sepsis in a medical intensive
care unit. Crit Care Med. 28:977–983. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bozza FA, Salluh JI, Japiassu AM, Soares
M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC and Bozza PT:
Cytokine profiles as markers of disease severity in sepsis: A
multiplex analysis. Crit Care. 11:R492007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wong HR, Cvijanovich N, Wheeler DS, Bigham
MT, Monaco M, Odoms K, Macias WL and Williams MD: Interleukin-8 as
a stratification tool for interventional trials involving pediatric
septic shock. Am J Respir Crit Care Med. 178:276–282. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei XQ, Leung BP, Niedbala W, Piedrafita
D, Feng GJ, Sweet M, Dobbie L, Smith AJ and Liew FY: Altered immune
responses and susceptibility to Leishmania major and Staphylococcus
aureus infection in IL-18-deficient mice. J Immunol. 163:2821–2828.
1999.PubMed/NCBI
|
|
27
|
Klein C, Wüstefeld T, Assmus U, Roskams T,
Rose-John S, Müller M, Manns MP, Ernst M and Trautwein C: The
IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection
in T cell-mediated liver injury. J Clin Invest. 115:860–869. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin MW, Lee DD, Liu TT, Lin YF, Chen SY,
Huang CC, Weng HY, Liu YF, Tanaka A, Arita K, et al: Novel IL31RA
gene mutation and ancestral OSMR mutant allele in familial primary
cutaneous amyloidosis. Eur J Hum Genet. 18:26–32. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Edukulla R, Singh B, Jegga AG, Sontake V,
Dillon SR and Madala SK: Th2 Cytokines augment IL-31/IL-31RA
interactions via STAT6-dependent IL-31RA expression. J Biol Chem.
290:13510–13520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lei Z, Liu G, Huang Q, Lv M, Zu R, Zhang
GM, Feng ZH and Huang B: SCF and IL-31 rather than IL-17 and BAFF
are potential indicators in patients with allergic asthma. Allergy.
63:327–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
